Tiamat Sciences

BiotechnologySeedDurham, UStiamat-sciences.com

Latest round

Seed

Last raised

Mar 2023

Total raised

$5M

Investors

10

About Tiamat Sciences

Based in North Carolina, US, and founded in 2019 by CEO France-Emmanuelle Adil and COO Clement Carlier, Tiamat Sciences is a biotech company developing the next generation of biomolecules using plants as bioreactors. The company uses a proprietary plant molecular farming approach to create animal-free proteins, which blends biotechnology, vertical farming, and computing design to reinvent recombinant proteins. These reimagined biomolecules are being used to power the next wave of biotechnology discoveries in domains like cellular agriculture and cultured meat, regenerative medicine, and the development of innovative vaccines.

Who invested in Tiamat Sciences

10 investors across 2 rounds

See all investors in Tiamat Sciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Mar 9, 2023

    Amount

    $2M

    Investors

    Locked

  2. Seed

    Nov 22, 2021

    Amount

    $3M

    Investors

    Locked

Questions about Tiamat Sciences

Who invested in Tiamat Sciences?

Tiamat Sciences has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Tiamat Sciences raised?

Tiamat Sciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Tiamat Sciences last raise money?

Tiamat Sciences's most recent round on record is a Seed, in Mar 2023.

What does Tiamat Sciences do?

Based in North Carolina, US, and founded in 2019 by CEO France-Emmanuelle Adil and COO Clement Carlier, Tiamat Sciences is a biotech company developing the next generation of biomolecules using plants as bioreactors.

Where is Tiamat Sciences headquartered?

Tiamat Sciences is headquartered in Durham, US.

Which VCs invest in companies like Tiamat Sciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tiamat Sciences's stage. Their profiles are linked below.

Raising like Tiamat Sciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.